Publication authors: Michele Laget

TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents

Original quinazoline derivatives displaying antiplasmodial properties

Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series

Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium

Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series

Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agents

Targeting the human parasite Leishmania donovani: Discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series

Targeting the human malaria parasite Plasmodium falciparum: In vitro identification of a new antiplasmodial hit in 4-phenoxy-2-trichloromethylquinazoline series

Discovery of a new antileishmanial hit in 8-nitroquinoline series

4-Thiophenoxy-2-trichloromethyquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparum

Synthesis and evaluation of original amidoximes as antileishmanial agents

Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity